GGH Pre Triage Protocol
GGH Pre Triage Protocol
GGH Pre Triage Protocol
1
Contents
Back Ground................................................................................................................................................3
Services Provided by GGH...........................................................................................................................4
Mission & Vision of GGH.............................................................................................................................5
Core Values of GGH.....................................................................................................................................6
Health Care Quality.....................................................................................................................................7
PRETRIAGE SCREENING FOR INFECTIOUS CASES.........................................................................................8
PRETRIAGE SCREENING & ISOLATION CRITERIA FOR COVID-19..............................................................9
Isolation Criteria for Tuberculosis..........................................................................................................13
PATIENTS CHANNELING TO COUGH CLINIC PROTOCOL.............................................................................14
COVID-19 & TB Screening, Isolation & Treatment Algorithm....................................................................15
2
Back Ground
Gambo General Hospital is found in Oromia regional state, 245 KMs to the
South of AA on Ethio-Kenya main road & 18KMs to the east of Arsi Negele
town in West Arsi Zone
Currently its labeled as General Hospital giving service for around 1 million
of population
3
Services Provided by GGH
1. General OPD services
3. Inpatient Services
4. OBS/GYN services
6. TB services
7. ART services
8. Leprosy services
9. Imaging services
4
Mission & Vision of GGH
1. Mission:- To reduce Morbidity, Mortality, Disability & Improve health
status of the Community through Provision of Preventive, Curative &
Rehabilitative health Services.
5
Core Values of GGH
1. Community First
2. Collaboration
3. Commitment
4. Change
5. Trust
6
Health Care Quality
The degree to which health services for individuals and populations increase the
likelihood of desired health outcomes and are consistent with current professional
knowledge OR
1. Safe: Avoiding injuries to patients from Care that is intended to help them.
Patient Safety is the prevention of errors & adverse effects to patients associated
with the health care.
3. Timely: reducing Waits & harmful delays for both who receive & those who
give care.
5. Equitable: Providing care that does not vary in quality because of personal
characteristics such as Gender, Ethnicity, Geographic Location & Socio economic
status.
7
PRETRIAGE SCREENING FOR
INFECTIOUS CASES
To reduce the risk of transmission of highly infectious diseases like suspected
COVID-19,TB & etc; patients entering the Emergency Department (ED)/OPD
were assigned to a high-risk (ED) or low-risk (acute medical unit, AMU) area
based on symptoms, travel and contact history.
The COVID-19 pandemic, caused by severe acute respiratory syndrome Corona
virus 2(SARS-CoV-2), has placed an ongoing burden on healthcare systems
globally. With increasing exposure to this new infectious disease, it became
apparent that COVID-19 patients could be relatively asymptomatic in the early
stages of illness or present with gastro-intestinal or atypical symptoms .Ultimately,
screening methods were highly susceptible to these changes.
Pre-triage screening was applied for possible COVID-19 infection based on the
most recent guidelines concerning symptoms, known COVID-19 contacts and
travel history.
A patient suspected for COVID-19 could be identified by the referring general
practitioner (GP), ambulance personnel or an ED nurse. The attending emergency
physician supervised the final decision on the patient’s allocation area.
The COVID-19 case definition in the Netherlands was determined by the Dutch
National Institute for Public Health and Environment. Early in the study period, the
case definition was relatively strict, including only patients with fever, respiratory
complaints and a positive contact and/or travel history. Later in the study period,
the case definition was further extended based on latest evidence, also including
8
patients with gastro-intestinal and non-specific symptoms. Non-specific symptoms
included loss of smell and taste and muscle ache.
Screen all patients for ANY of the following symptoms within the last 7
days:-
COVID-19 Core Respiratory Symptoms (new or worse):
Cough
Fever/chills/rigors
Adults >37.8°C (reported or documented)
Pediatrics ≥38.0°C (reported or documented)
Shortness of breath, increased O2 requirements,
difficulty breathing, Sore throat/painful swallowing
Runny nose/nasal congestion
Physician instructions
• For Patients whose pre-triage/triage have screened as positive for COVID-
19 symptoms/risk factors; Contact & Droplet precaution is indicated.
Wearing PPE (i.e., procedure/surgical mask, eye/face protection, gown,
gloves) before assessing patient is mandatory
• Complete patient history (including confirming travel and exposure
history) and physical exam;
• Consider COVID-19 testing if the patient has new or worse, and
11
unexplained symptoms from the Expanded Symptoms list:
Headache
Altered mental status
Myalgia (muscle pain)/arthralgia (joint pain)
Loss of/change to sense of smell(anosmia)/taste (dysgeusia)
Fatigue/extreme exhaustion Conjunctivitis/red eye/chemosis (conjunctival
edema)
Nausea/sudden loss of appetite Any additional symptoms at clinician’s
discretion (e.g. skin manifestations such as “COVID toes”)
• If there is a plausible, alternate (non-COVID-19) clinical diagnosis and
patient does not have any risk factors as determined by the MRHP, COVID-
19 testing is not required.
• Patients who meet the expanded symptom criteria and who do not have
other risk factors do not require Contact and Droplet precautions.
• All patients being admitted to hospital with symptoms consistent with
COVID-19 should be tested
All symptoms/risks will be communicated to the receiving unit on admission
A nasopharyngeal or throat swab, collected under strict Contact and Droplet
precautions and transported in viral transport medium, should be submitted.
• Presenting symptoms, date of symptom onset and travel history, including
country of
travel and return date, must be included.
• Advise all patients and close contacts to follow public health directions to
self-isolate.
12
COVID-19 SCREENING &EVALUATION FLOW CHART
13
PATIENTS CHANNELING TO COUGH
CLINIC PROTOCOL
Once pre-triage screening is conducted; patients with likely hood of being
infectious like patients with COVID-19 suspect & Presumptive Tuberculosis, must
be isolated in order to prevent other patients & staffs from being infected
These patients are directed to cough corner waiting area to wait until their admin
issues are completed by their attendant/ hospital staff if patients have no attendant.
These patients will be given PPE like face mask & ordered on other safety issues to
control infection. Cough Clinic Health care professionals must be informed early
so that they can prepare themselves for evaluating the coming patients. After
Completion of admin issues patients will be directed to Cough Clinic for
evaluation by physician & nurses assigned on Cough clinic.
If a patient is critical like patient who needs oxygen, then admission to integrated
COVID-19 & TB ward is a rule, where treatment & evaluation are cascaded
simultaneously.
14
COVID-19 & TB Screening, Isolation &
Treatment Algorithm
15